Abstract
Two gastrointestinal peptides, vasoactive intestinal polypeptide (VIP) and pancreatic polypeptide, suspected of being associated with symptoms of WDHA syndrome (pancreatic cholera) were tested on the rat small and large intestine for their effects on water and electrolyte transport. Intravenous infusion of VIP (14.3 μg/kg/hr) inhibited net absorption of water and electrolytes in the ileum and reversed net absorption to net secretion in the colon. In contrast, bovine pancreatic polypeptide (52 μg/kg/hr) did not inhibit absorption or stimulate secretion. These data indicate VIP causes colonic secretionin vivo, an effect previously shown onlyin vitro, and that bovine pancreatic polypeptide (at this dose) is not a secretagogue in the small or large intestine of the rat. Thus, while consistent with VIP being a contributory agent to the secretion of pancreatic cholera, the data do not support the notion that pancreatic polypeptide might be a causative agent in this syndrome.
Similar content being viewed by others
References
Verner JV, Morrison AB: Islet cell tumour and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 25:374–384, 1975
Verner JV, Morrison AB: Nonbeta islet cell tumours and the syndrome of watery diarrhea, hypokalemia and hypochlorhydrial. Clin Gastroenterol 3:595–608, 1974
Zollinger RM: Islet cell tumors of the pancreas and the alimentary tract. Am J Surg 129:102–110, 1975
Larsson LI, Schwartz T, Lundqvist G, Chance RE, Sundler F, Rehfeld JF, Grimelius L, Fahrenkrug J, Schaffalitzky de Muckadell O, Moon N: Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Am J Pathol 85:675–682, 1976
Polak JM, Bloom SR, Adrian TE, Heitz PH, Bryant MG, Pearse AGE: Pancreatic polypeptide in insulinomas, gastrinomas, VIPomas and glucagonomas. Lancet 1:328–330, 1976
Sanzenbacher LJ, Mekhjian HS, Kind DR, Zollinger RM: Studies on the potential role of secretin in the islet cell tumor diarrheogenic syndrome. Ann Surg 176:394–402, 1972
Barbezat GO, Grossman MI: Cholera-like diarrhea induced by glucagon plus gastrin. Lancet 1:1025–1026, 1971
Elias E, Bloom SR, Welbourn RB, Kuzio M, Polak JM, Pearse AGE, Booth CC, Brown J: Pancreatic cholera due to production of gastric inhibitory polypeptide. Lancet 2:791–793, 1972
Bloom SR, Polak JM, Pearse AGE: Vasoactive intestinal polypeptide and watery diarrhea syndrome. Lancet 2:14–16, 1973
Said SI, Faloona GR: Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery diarrhea syndrome due to pancreatic, bronchogenic and other tumors. N Engl J Med 293:155–160, 1975
Phillips SF, Gaginella TS: Intestinal secretion as a mechanism in diarrheal disease. Progress in Gastroenterology, Vol. III. B. Jerzy Glass (ed). New York, Grune Stratton, 1977, pp 481–504
Pearse AGE, Polak JM, Bloom SR: The newer gut hormones. Cellular sources, physiology, pathology and clinical aspects. Gastroenterology 72:746–761, 1977
Jansson R, Steen G, Svanvik J: Effects of intravenous vasoactive intestinal peptide (VIP) on gallbladder function in the cat. Gastroenterology 75:47–50, 1978
Kimmel JR, Pollock HG, Hazelwood RL: Isolation and characterization of chicken insulin. Endocrinology 83:1323–1330, 1968
Lin TM, Chance RE: Gastrointestinal actions of a new bovine pancreatic peptide (BPP). Endocrinology of the Gut. WW Chey, FP Brooks (eds). Thorofare, New Jersey, Charles B. Slack, 1974, pp 143–145
Lin TM, Evans DC, Chance RE, Spray GF: Bovine pancreatic peptide: Action on gastric and pancreatic secretion in dogs. Am J Physiol 232:E311-E315, 1977
Floyd JC, Jr, Fajans SS, Pek S, Chance RE: A newly recognized pancreatic polypeptide plasma level in health and disease. Recent Progress in Hormone Research. Proceedings of the 1976 Laurentian Hormone Conference, RO Greep (ed). New York, Academic Press, 1977, pp 519–556
Lin TM, Chance RE: Candidate hormones of the gut. Bovine pancreatic polypeptide (BPP) and avian pancreatic peptide (APP). Gastroenterology 67:737–739, 1974
Lin TM, Chance RE: Spectrum of gastrointestinal actions of bovine PP Gut Hormones, SR Bloom (ed). London, Churchill-Livingstone, 1978, pp 242–246
Bright-Asare P, Binder HJ: Stimulation of colonic secretion of water and electrolytes by hydroxy fatty acids. Gastroenterology 64:81–88, 1973
Steel RGD, Torrie JH: Principles and Procedures of Statistics. New York: McGraw-Hill, 1960
Gaginella TS, Mekhjian HS, O'Dorisio TM: Vasoactive intestinal polypeptide: Quantification by radioimmunoassay in isolated cells, mucosa and muscle of the hamster intestine. Gastroenterology 74:718–721, 1978
Hunter WM, Greenwood FC: Preparation of131I-labeled human growth hormone of high specific activity. Nature 194:495–496, 1962
Schwartz TW, Rehfield JF, Stadel F: Pancreatic polypeptide response to food in duodenal ulcer patients before and after vagotomy. Lancet 1:1102–1104, 1976
Gardner JD: Plasma VIP in patients with watery diarrhea syndrome. Am J Dig Dis 23:370–373, 1978
Bloom SR: Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: Value of measurement in diagnosis and treatment. Am J Dig Dis 23:373–376, 1978
Krejs GJ, Walsh JH, Morawski SG, Fordtran JS: Intractable diarrhea. Intestinal perfusion studies and plasma VIP concentrations in patients with pancreatic cholera syndrome and surreptitious ingestion of laxative and diuretics. Am J Dig Dis 22:280–292, 1977
Krejs GJ, Barkley RM, Read NW, Fordtran JS: Intestinal secretion induced by vasoactive intestinal polypeptide, a comparison with cholera toxin in the canine jejunumin vivo. J Clin Invest 61:1337–1345, 1978
Coupar IM: Stimulation of sodium and water secretion with-out inhibition of glucose absorption in the rat jejunum by vasoactive intestinal peptide (VIP). Clin Exp Pharmacol Physiol 3:615–618, 1976
Barbezat GO, Grossman MI: Intestinal secretion: Stimulation by peptides. Science 174:422–423, 1971
Schwartz CJ, Kimberg DV, Sheerin HE, Field M, Said SI: Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa. J Clin Invest 54:536–544, 1974
Racusen LC, Binder HJ: Alteration of large intestinal electrolyte transport by vasoactive intestinal polypeptide in the rat. Gastroenterology 73:790–796, 1977
Waldman DB, Gardner JD, Zfass AM, Makhlouf GM: Effects of vasoactive intestinal peptide, secretin and related peptides on rat colonic transport and adenylate cyclase activity. Gastroenterology 73:518–523, 1977
Gaginella TS, Phillips SF, Dozois RR, Go VLW: Stimulation of adenylate cyclase in homogenates of isolated intestinal epithelial cells from hamsters. Effects of gastrointestinal hormones, prostaglandins and deoxycholic and ricinoleic acids. Gastroenterology 74:11–15, 1978
Jaffe BM, Kopen DF, DeSchryver-Kecskemeti K, Gingerich R, Greider M: Indomethacin-responsive pancreatic cholera. N Engl J Med 297:817–821, 1977
Taylor IL, Solomon TE, Walsh JH, Grossman MI: Physiological blood levels of pancreatic polypeptide (PP) inhibit pancreatic secretion (abstract). Gastroenterology 74:1102, 1978
Greenberg GR, McCloy RF, Chadwick VS, Adrian TE, Baron JH, Bloom SR: Effect of bovine pancreatic polypeptide on basal pancreatic and biliary outputs in man. Dig Dis Sci 24:11–14, 1979
Chance RE, Jones WE: United States Patent Office, October 15, 1974
Author information
Authors and Affiliations
Additional information
This work was supported in part by NCI Grant CA 16058-05 and funds from the graduate school of the Ohio State University. Dr. Gaginella is the recipient of Research Career Development Award 1 KO4 AM 00471-01 from the National Institute of Arthritis, Metabolism and Digestive Diseases. Dr. O'Dorisio is recipient of a Clinical Associate Physician Award (NIH-GCRC, RR-34).
Rights and permissions
About this article
Cite this article
Wu, Z.C., O'Dorisio, T.M., Cataland, S. et al. Effects of pancreatic polypeptide and vasoactive intestinal polypeptide on rat ileal and colonic water and electrolyte transportin vivo . Digest Dis Sci 24, 625–630 (1979). https://doi.org/10.1007/BF01333707
Issue Date:
DOI: https://doi.org/10.1007/BF01333707